Clinical Trial

A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Phase 1 Safety and Relative Bioavailability Study of DWRX5003 in Healthy Adults
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-17
notable Primary completion pushed: 2026-04-30 -> 2026-10-27 2026-07-17
minor Completion pushed: 2026-08-30 -> 2026-11-17 2026-07-17
Trial Details
NCT Number NCT07539415
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Obesity & Overweight, Type 2 Diabetes
Enrollment 72 participants
Start Date 2026-05-06
Primary Completion 2026-10-27 (estimated)
Study Completion 2026-11-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-16